Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 52-1732704 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To develop, implement and promote voluntary guidance and other programs for the world Pharmaceutical industry that are designed to ensure that Excipients and related components in finished drug products meet only the highest appropriate standards for quality, safety, and functionality throughout their manufacturing process; and to encourage and assist the adoption of scientifically suitable and valid regulatory and compendial standards for Pharmaceutical Excipients.
Total Revenue
$1.5M
FY2024
Total Expenses
$1.7M
FY2024
Net Assets
$1.3M
Program Ratio
88.1%
expenses on programs
Employees
4
Volunteers
—
Board Members
13
Voting
13
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.